In the past week, ABSI stock has gone up by 12.98%, with a monthly decline of -3.30% and a quarterly plunge of -19.90%. The volatility ratio for the week is 9.31%, and the volatility levels for the last 30 days are 11.38% for Absci Corp. The simple moving average for the past 20 days is 9.72% for ABSI’s stock, with a -18.65% simple moving average for the past 200 days.
Is It Worth Investing in Absci Corp (NASDAQ: ABSI) Right Now?
The 36-month beta value for ABSI is at 2.06. Analysts have varying views on the stock, with 5 analysts rating it as a “buy,” 3 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for ABSI is 92.27M, and currently, shorts hold a 16.79% of that float. The average trading volume for ABSI on January 22, 2025 was 3.05M shares.
ABSI) stock’s latest price update
The stock price of Absci Corp (NASDAQ: ABSI) has jumped by 11.03 compared to previous close of 2.90. Despite this, the company has seen a gain of 12.98% in its stock price over the last five trading days. seekingalpha.com reported 2025-01-13 that Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. ABS-101 appears to be ABSI’s main drug candidate for IBD. However, ABS-201 for hair loss and ABS-301 for solid tumors offer additional sizeable TAMs if successful. ABSI’s AI models and wet lab data seem quite promising for discovering further antibodies that could be highly differentiated from other competitors.
Analysts’ Opinion of ABSI
Many brokerage firms have already submitted their reports for ABSI stocks, with Guggenheim repeating the rating for ABSI by listing it as a “Buy.” The predicted price for ABSI in the upcoming period, according to Guggenheim is $10 based on the research report published on October 02, 2024 of the previous year 2024.
Morgan Stanley, on the other hand, stated in their research note that they expect to see ABSI reach a price target of $7. The rating they have provided for ABSI stocks is “Overweight” according to the report published on July 03rd, 2024.
Scotiabank gave a rating of “Sector Outperform” to ABSI, setting the target price at $13 in the report published on March 14th of the previous year.
ABSI Trading at 2.45% from the 50-Day Moving Average
After a stumble in the market that brought ABSI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -52.08% of loss for the given period.
Volatility was left at 11.38%, however, over the last 30 days, the volatility rate increased by 9.31%, as shares surge +5.92% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -20.49% lower at present.
During the last 5 trading sessions, ABSI rose by +12.98%, which changed the moving average for the period of 200-days by -39.36% in comparison to the 20-day moving average, which settled at $2.93. In addition, Absci Corp saw 22.90% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ABSI starting from Jonasson Zachariah, who sale 19,859 shares at the price of $4.98 back on Jun 13 ’24. After this action, Jonasson Zachariah now owns 384,751 shares of Absci Corp, valued at $98,892 using the latest closing price.
Phoenix Venture Partners II LP, the 10% Owner of Absci Corp, sale 3,100,000 shares at $4.40 during a trade that took place back on May 22 ’24, which means that Phoenix Venture Partners II LP is holding 11,279,522 shares at $13,640,000 based on the most recent closing price.
Stock Fundamentals for ABSI
Current profitability levels for the company are sitting at:
- -24.57 for the present operating margin
- -1.44 for the gross margin
The net margin for Absci Corp stands at -23.22. The total capital return value is set at -0.5. Equity return is now at value -49.11, with -41.42 for asset returns.
Based on Absci Corp (ABSI), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -5.87. The debt to equity ratio resting at 0.06. The interest coverage ratio of the stock is -156.6.
Currently, EBITDA for the company is -95.46 million with net debt to EBITDA at 0.31. When we switch over and look at the enterprise to sales, we see a ratio of 81.68. The receivables turnover for the company is 2.8for trailing twelve months and the total asset turnover is 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.63.
Conclusion
In conclusion, Absci Corp (ABSI) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
